FDA Plays

[newtostocks23]

IMO, it will take time for $CBLI to progress. The major reason for the sell off and probably the reasoning for the dilution was because of the delay with BARDA. They have to resubmit a new proposal and wait for a reply.

BARDA has indicated that the Company may resubmit an updated proposal upon confirmation from the FDA there are no objections to the Company proceeding with its development plan as a result of this review

http://yhoo.it/l3bOY9

I'm unsure on how long this will take and what the turnaround time is for a re-submission of a proposal. However, I don't think many will argue that their product CBLB502 is currently the best option for ARS.